Human Th17 state classification reveals a selective vulnerability in acylcarnitine metabolism in type 2 diabetes
Naveena S. Ujagar, Suresh Poudel, SHUBH SARASWAT, Suhas Sureshchandra, Josh Kim, Uyen-Vy Le, Albert R. Jones, Nicole Hopkins, Trupti Sriram, Matthew Matson, Emely Henriquez Pilier, Marlyd Mejia, Samuel S. Bailin, Celestine N. Wanjalla, Michael Y. Sy, , Dequina Nicholas
The paper classifies human Th17 cells into non-pathogenic and pathogenic states and identifies acylcarnitine metabolism as a vulnerability in type 2 diabetes.
bioRxiv · Oct 10, 2026 · PreprintImmunology